Kartik K Venkatesh Selected Research

Generic Drugs

7/2012

Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are needed.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kartik K Venkatesh Research Topics

Disease

5	HIV Infections (HIV Infection) 01/2022 - 04/2009
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2013 - 09/2008
3	Premature Birth (Birth, Premature) 01/2022 - 01/2016
3	Exanthema (Rash) 07/2019 - 04/2008
2	COVID-19 01/2022 - 01/2022
2	Human Influenza (Influenza) 01/2022 - 05/2021
2	Substance-Related Disorders (Drug Abuse) 01/2022 - 11/2008
2	Hypersensitivity (Allergy) 01/2021 - 07/2019
2	Chorioamnionitis 11/2020 - 01/2020
2	Necrotizing Enterocolitis 01/2020 - 01/2019
2	Nausea 07/2019 - 06/2009
2	Neoplasms (Cancer) 01/2019 - 05/2016
2	Inflammation (Inflammations) 01/2019 - 03/2011
2	Sepsis (Septicemia) 01/2019 - 12/2015
2	Tuberculosis (Tuberculoses) 01/2013 - 06/2011
2	Immune Reconstitution Inflammatory Syndrome 01/2013 - 06/2011
2	Anemia 11/2009 - 04/2008
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Diphtheria 01/2022
1	Obesity 01/2022
1	Tetanus 01/2022
1	Whooping Cough (Pertussis) 01/2022
1	Diseases Newborn Infant 01/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2020
1	Fever (Fevers) 01/2020
1	Infections 01/2020
1	Hemorrhage 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Surgical Wound Infection 01/2020
1	Anaphylaxis (Anaphylactic Shock) 07/2019
1	Dyspnea (Shortness of Breath) 07/2019
1	Urticaria (Hives) 07/2019
1	Vomiting 07/2019
1	Pruritus (Itching) 07/2019
1	Perinatal Death 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Cerebral Hemorrhage 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Bacteremia 12/2015
1	HIV Seropositivity 08/2011
1	Drug-Related Side Effects and Adverse Reactions 06/2011
1	Herpes Simplex 06/2011
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 03/2011
1	Bacterial Vaginosis 09/2009
1	Disease Progression 11/2008
1	Retinitis 09/2008
1	Opportunistic Infections (Opportunistic Infection) 09/2008
1	Hepatitis 04/2008
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2008
1	Jaundice (Icterus) 04/2008

Drug/Important Bio-Agent (IBA)

3	Penicillins (Penicillin)FDA Link 01/2021 - 07/2019
2	VaccinesIBA 01/2022 - 11/2008
2	Hemoglobins (Hemoglobin)IBA 12/2020 - 04/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 07/2019
2	Stavudine (Zerit)FDA LinkGeneric 11/2009 - 04/2008
1	COVID-19 VaccinesIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022
1	cyclo(Arg-Pro) (CI 4)IBA 01/2021
1	Dihydrotachysterol (AT 10)IBA 11/2020
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2020
1	Cefazolin (Ancef)FDA LinkGeneric 01/2020
1	Metronidazole (Metric)FDA LinkGeneric 01/2020
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2020
1	Clindamycin (Cleocin)FDA LinkGeneric 01/2020
1	Cephalosporins (Cephalosporin Antibiotics)IBA 07/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2016
1	Generic DrugsIBA 07/2012
1	Biological ProductsIBA 03/2011
1	Zidovudine (Retrovir)FDA LinkGeneric 11/2009
1	Alanine Transaminase (SGPT)IBA 04/2008

Therapy/Procedure

9	Therapeutics 01/2022 - 04/2008
8	Highly Active Antiretroviral Therapy (HAART) 01/2013 - 04/2008
2	Art Therapy 01/2022 - 06/2011
2	Critical Care (Surgical Intensive Care) 05/2021 - 12/2015
2	Antibiotic Prophylaxis 01/2021 - 07/2019
2	Artificial Respiration (Mechanical Ventilation) 01/2020 - 01/2019
2	Hysterectomy 01/2019 - 05/2016
1	Prenatal Care (Care, Prenatal) 01/2022
1	Long-Acting Reversible Contraception 01/2019
1	Tubal Sterilization (Tubal Ligation) 01/2019
1	Salpingectomy 01/2019
1	Condoms (Condom) 08/2011
1	Female Condoms (Female Condom) 08/2011
1	Secondary Prevention 08/2011